CollPlant Biotechnologies Ltd CLGN

NAS: CLGN | ISIN: US19516R1077   26/04/2024
5,890 USD (+9,89%)
(+9,89%)   26/04/2024

4 april 2024 · Collplant Biotechnologies Reports 2023 Full Year Financial Results And Provides Corporate Update · Persbericht

4 april 2024 · Collplant Biotechnologies Reports 2023 Full Year Financial Results And Provides Corporate Update · Persbericht

26 maart 2024 · Collplant Biotechnologies Announces Date For 2023 Full Year Financial Results And Conference Call Information · Persbericht

15 februari 2024 · CollPlant Issues Letter to Shareholders · Persbericht

8 januari 2024 · CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California · Persbericht

21 september 2023 · CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative · Persbericht

9 augustus 2023 · Collplant Biotechnologies Announces Date For 2023 Second Quarter Financial Results And Conference Call Information · Persbericht

9 augustus 2023 · Collplant Biotechnologies Announces Date For 2022 First Quarter Financial Results And Conference Call Information · Persbericht

24 mei 2023 · CollPlant Biotechnologies Announces First Quarter Financial Results For 2023 and Provides Corporate Update · Persbericht

2 mei 2023 · Collplant Biotechnologies Announces Date For 2023 First Quarter Financial Results And Conference Call Information · Persbericht

29 maart 2023 · Collplant Biotechnologies Announces Full-Year Financial Results For 2022 and Provides Corporate Update · Persbericht

14 maart 2023 · Collplant Biotechnologies Announces Date For 2022 Full Year Financial Results And Conference Call Information · Persbericht

3 januari 2023 · CollPlant Enriches Portfolio of rhCollagen-Based Bioinks with Launch of Collink.3DTM 50L in Powder Form · Persbericht

1 december 2022 · CollPlant Biotechnologies Provides Business Updates and Third Quarter 2022 Financial Results · Persbericht

15 november 2022 · CollPlant, Tel Aviv University and Sheba Medical Center Join Forces to Co-Develop rhCollagen-Based 3D Bioprinted Human Intestine Model for Drug Discovery and Personalized Treatment of Ulcerative Colitis · Persbericht

7 november 2022 · CollPlant Expands rhCollagen-Based Bioink Platform with Launch of Collink.3D™ 90 · Persbericht

3 november 2022 · CollPlant to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 17 · Persbericht

3 oktober 2022 · CollPlant to present at the Dawson James Small Cap Growth Conference on October 12 · Persbericht

19 september 2022 · CollPlant to Present at the International Conference on Biofabrication 2022 in Tuscany, Italy · Persbericht

Mijn selecties